
Healio Pulmonology
@healiopulm
The content you need, when you need it.
ID: 3043251863
http://healio.com/pulmonology 17-02-2015 18:19:32
9,9K Tweet
1,1K Followers
814 Following

💬"The studies suggest the imminent need for overall improvement in resources within the health care systems for #PAH patients' comprehensive care," Anjali Vaidya MD 🫀, FACC, FASE, FACP, Temple Health, told Healio. #ATS2025 healio.com/news/pulmonolo…

🗨️"Azithromycin did not decrease the severity of #wheezing illnesses in these children, even if they were positive for #bacteria that are considered usually pathogenic in this age group,” Fernando D. Martinez, MD, University of Arizona, said at #ATS2025. healio.com/news/pulmonolo…

👩⚕️Nurses in a critical care unit reported less #burnout and more resiliency once a full-time therapist joined their team, with turnover falling to 1%, Dr. Julie-Kathryn Graham of San Diego State University School of Nursing said at #ATS2025. American Thoracic Society (ATS) healio.com/news/pulmonolo…

At #ATS2025: Greater frailty, older age and worse cognition heightened📈 the odds for a post-intensive care syndrome recovery trajectory in #ICU survivors. American Thoracic Society (ATS) Vanderbilt University Medical Center healio.com/news/pulmonolo…


A therapist embedded with a critical care 👩⚕️nursing team participated in rounding and codes while coaching nurses and teaching them how to use self-care tools, Dr. Julie-Kathryn Graham of San Diego State University School of Nursing said at #ATS2025. American Thoracic Society (ATS) healio.com/news/pulmonolo…

❗ Improvements in FEV1 included 230 mL with 150 mg of #rademikibart, 279 mL with 300 mg of rademikibart, and 89 mL with placebo at week 24, Dr. Barry Quart of Connect Biopharma said at #ATS2025. Healio Pulmonology American Thoracic Society (ATS) #asthma healio.com/news/allergy-a…

💬"These findings give us a better understanding of how different domains of function change over time for patients with PICS,” Justin Banerdt, MD, MPH, Vanderbilt University Medical Center, told Healio. #ATS2025 healio.com/news/pulmonolo…


💬"In patients with progressive pulmonary fibrosis, nerandomilast slows #FVC decline. It also appeared to have a very favorable effect on mortality and had a trend on the key secondary endpoint," Toby Maher, MD, PhD, Keck School of Medicine of USC, said at #ATS2025. healio.com/news/pulmonolo…

At #ATS2025: Among adults with #ILD requiring #ICU care, women👩 faced a lower adjusted likelihood for mortality vs. men👨. American Thoracic Society (ATS) Temple Health healio.com/news/pulmonolo…

Physicians can use peak expiratory flow as a simple and inexpensive first-line tool for assessing variable airflow limitations among patients with #asthma, Dr. Anne-Marie Sweeney of St. Vincent’s University Hospital said at #ATS2025. American Thoracic Society (ATS) healio.com/news/allergy-a…

💬"We encourage clinicians to recognize that men [with #ILD] may have unique risk factors and might require more aggressive monitoring or early interventions," Matthew Viggiano, MD, Temple Health, told Healio. #ATS2025 healio.com/news/pulmonolo…


At #ATS2025: Patient groups with reduced odds for #ECMO had shorter travel distances🚗 to a hospital🏥 with this resource. American Thoracic Society (ATS) CU Pulmonary & Critical Care Medicine healio.com/news/pulmonolo…

The risk for #fertility👶 treatment rose among women with vs. without #asthma, and those with severe asthma and past #exacerbations faced a greater risk, according to data published in JACI In Practice. Healio Pulmonology Healio Women’s Health & OB/GYN healio.com/news/allergy-a…

#REM sleep, antidepressants and #ALS survival rates are intertwined and researchers at Emory School of Medicine presented their findings at #ATS2025: tinyurl.com/yy486wfz The ALS Association American Academy of Sleep Medicine American Thoracic Society (ATS) Healio Pulmonology

💬"Patients who were least likely to receive #ECMO actually lived closer to ECMO-capable hospitals🏥,” Gwenyth L. Day, MD, CU Pulmonary & Critical Care Medicine, told Healio. #ATS2025 healio.com/news/pulmonolo…

Patients with #COPD and type 2 inflammation receiving #mepolizumab vs. placebo had decreased moderate and severe #exacerbation rates and fewer ED visits per exacerbation at 104 weeks, according to data at #ATS2025. American Thoracic Society (ATS) Lewis Katz School of Medicine Temple Lung Center healio.com/news/pulmonolo…

🚨The #FDA granted approval to #mepolizumab for treating adults with inadequately controlled #COPD and an #eosinophilic phenotype, according to a GSK press release. 💬Mike Hess (Mike Hess, #TeamOxyphile🫁 🌬️), MPH, RRT, RPFT, COPD Foundation, shares his perspective. healio.com/news/pulmonolo…